Dostinex 0,5 mg tablete
| Name | Dostinex 0,5 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-951850722 |
| Active Substance | kabergolin |
| Composition | jedna tableta sadrži 0,5 mg kabergolina |
| Pharmaceutical Form | tableta |
| Packaging [MA Number for Packaging] | 2 tablete u bočici, u kutiji [HR-H-951850722-01] 4 tableta u bočici, u kutiji [HR-H-951850722-02] 8 tableta u bočici, u kutiji [HR-H-951850722-03] |
| Manufacturer | Pfizer Italia S.r.l., Ascoli Piceno, Italija |
| Marketing Authorisation Holder | Pfizer Croatia d.o.o., Slavonska avenija 6, Zagreb, Hrvatska |
| Marketing Authorisation Date | 07.04.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/647 |
| Registration Number | 381-12-01/70-20-07 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | G02CB03 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
